Temporomandibular disorders are characterized by pain and tenderness in the muscles of mastication and/or the temporomandibular joint (TMJ), limitations of jaw opening often accompanied by deviations in mandibular path, and clicking, popping or grating TMJ sounds. This Phase II clinical trial will evaluate whether selected complementary approaches to TMD pain management-acupuncture (n=100), chiropractic therapy (n=50), and bodywork therapy (n=50)-delivered by complementary practitioners is as effective as usual TMD care (n=50) provided by clinicians in the KPNW TMD clinic. Subjects will be 18-70 years of age and psychologically functional TMD patients. Functional TMD patients are defined as minimally impacted by their TMD condition, reporting low-moderate pain that is not associated with activity limitation, undue reliance on health care, or psychological disturbance. Subjects will be evaluated at baseline, and six and 12 months post-intervention. Clinical examinations, saliva samples to assess salivary cortisol levels, and a series of questionnaires to assess pain and grade of dysfunctional pain, psychological functioning, and other physical symptoms will be used to assess outcomes. The investigators will passively monitor health care utilization within KPNW using clinical, research, and administrative databases. If these complementary interventions are shown to be effective, the goal is to design and implement a Phase III clinical trial to further evaluate the health consequences and cost of these therapies.

Condition	Treatment or Intervention	Phase
Temporomandibular Joint Disorders	Procedure: Acupuncture  Procedure: chiropractic therapy  Procedure: bodywork therapy	Phase II

Ages Eligible for Study:  18 Years   -   70 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Psychologically functional TMD patients

Alex White      1-503-335-6765    alex.white@kpchr.org

Oregon
      Center for Health Research, Portland,  Oregon,  97227-1110,  United States; Recruiting

Study chairs or principal investigators

Alex White,  Principal Investigator,  Center for Health Research (CHR), Kaiser Foundation Hospitals   

Study ID Numbers:  1 P50 AT00076-01P1; 1 P50 AT00076-01
Record last reviewed:  January 2001
Last Updated:  October 13, 2004
Record first received:  February 2, 2001
ClinicalTrials.gov Identifier:  NCT00010621
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08